Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Annual General Meeting Lack of Quorum

30 Jul 2024 07:00

RNS Number : 2905Y
Spectra Systems Corporation
30 July 2024
 

Spectra Systems Corporation

("The Company" or "Spectra")

Annual General Meeting Lack of Quorum, Removal of Regulation S restrictions from shares and Exercise of Options

Spectra (AIM: SPSY.L) announces that, having received only 8 ballots, it does not have enough shareholder votes to achieve a quorum to transact business at its scheduled 2024 Annual General Meeting on 29 July 2024. The presence in person or by proxy, duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote constitutes a quorum.

A summary of the votes received is as follows:

Resolution

For

Against

Discretion

Withheld

Total

Elect BJ Penn as Director

 

12,162,853

 

 

1,300,348

-

-

 

13,463,201

 

Elect Nabil Lawandy as Director

 

13,462,853

 

348

-

-

 

13,463,201

 

Elect Jeremy Fry as Director

 

12,162,853

 

 

1,300,348

-

-

 

13,463,201

 

Elect Donald Stanford as Director

 

12,162,853

 

 

1,300,348

-

-

 

13,463,201

 

Elect Barbara Paldus as Director

 

12,162,853

 

 

1,300,348

-

 

13,463,201

Ratification of Appointment of Independent Auditor

 

10,417,053

 

 

1,320,348

 

-

 

1,725,800

 

 

11,737,401

 

 

Total shares of stock outstanding as of the record date of 28 June 2024 was 48,228,972. Therefore, only approximately 28% of the shares of stock were voted.

Removal of Regulation S restrictions from shares

Restrictive legends have also been removed from a further 36,072 shares of common stock of the Company.

As a result, these share have transferred from the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC) into the unrestricted line ISIN number US84756T1060 (AIM:SPSY).

Exercise of Options

An employee has exercised options over 10,000 shares of common stock of $0.01 each in the Company ("Shares") with an exercise price of $0.32 per share on 3 June 2024. The employee has elected to utilize the net cashless exercise feature and has therefore surrendered 1,105 shares to the Company. The employee will be issued 8,995 shares. The shares being issued are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.

Accordingly the Company has issued and will apply for 8,995 shares to be admitted to trading on AIM, which is expected to take place on or around 2 August 2024 ("Admission").

Following Admission the Company's issued share capital will comprise:

· 752,618 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and

· 47,476,354 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA ("DTRs"), the issued share capital of Spectra upon Admission is 48,228,972 shares with voting rights attached (one vote per share). There are no shares held in treasury, therefore this figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Spectra under the DTRs.

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

Zeus Capital Limited (Nominated Adviser and Broker)

Chris Fielding (Head of Corporate Finance)

Andrew de Andrade (Executive, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 3829 5000

 

 

 

Tel: +44 (0)20 3328 5665

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQKCBPCBKDDOB
Date   Source Headline
22nd May 20262:45 pmRNSAdditional Sensor order
16th Apr 20267:00 amRNSExercise of Options and Total Voting Rights
8th Apr 20267:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20267:00 amRNSAudited results for year ended 31 December 2025
5th Feb 20267:00 amRNSExecuted Contract with HMRC for Vaping Duty Stamps
16th Jan 20267:00 amRNSSuccessful Bid for HMRC Vaping Duty Stamps Scheme
8th Dec 20257:00 amRNSTransaction in Own Shares & TVR
26th Nov 20257:01 amRNSTransaction in Own Shares & TVR
26th Nov 20257:00 amRNSMaintenance contract for new sensors
25th Nov 20257:00 amRNSShare Buyback Programme
16th Oct 20257:00 amRNSAppointment of Finance Director
29th Sep 20257:00 amRNSInterim Results for Six Months Ended 30 June 2025
9th Sep 20252:59 pmRNSNotice of Interim Results
27th Jun 20257:00 amRNSExercise of Options
24th Jun 20254:48 pmRNSAnnual General Meeting Lack of Quorum
11th Jun 20257:00 amRNSNotice of AGM
27th May 20255:33 pmRNSAppointment of Finance Director
9th Apr 20254:55 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSExercise of Options & Removal of Reg S
31st Mar 20257:00 amRNSAudited results for year ended 31 December 2024
9th Jan 20257:00 amRNSExercise of Options
18th Dec 20243:58 pmRNSExercise of Options
18th Dec 20247:00 amRNS$9.4M downpayment on sensor manufacturing contract
21st Oct 20244:00 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSInterim Results
20th Aug 20244:35 pmRNSRemoval of Reg S restrictions from common stock
30th Jul 20247:00 amRNSAnnual General Meeting Lack of Quorum
18th Jul 20244:52 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSNew $37.9 million sensor manufacturing contract
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
28th Jun 20241:46 pmRNSReplacement: Posting of Annual Report
28th Jun 202410:14 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20247:00 amRNSIssue of Equity & Update to Dividend Timetable
27th Mar 20247:00 amRNSAudited results for 12 months ended 31 Dec 2023
11th Jan 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
28th Dec 20237:00 amRNSExercise of Options
21st Dec 202312:15 pmRNSCompletion of Acquisition
15th Dec 20234:35 pmRNSExercise of Options and transfer of shares
4th Dec 20237:00 amRNSAcquisition of Cartor Holdings Limited
6th Nov 20234:43 pmRNSTR-1
12th Oct 20237:00 amRNSLargest Central Bank Consumables Order
25th Sep 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
7th Jul 20236:01 pmRNSRemoval of Regulation S restrictions from shares
26th Jun 20233:22 pmRNSAnnual General Meeting Lack of Quorum
30th May 20237:00 amRNSAppointment of Chief Financial Officer
25th Apr 20237:00 amRNSAdditional Sensor Services Contract Amendment
24th Apr 20237:00 amRNSResignation of Chief Financial Officer
19th Apr 20237:05 amRNSRemoval of Reg S restrictions from common stock
6th Apr 20237:00 amRNSExercise of Options
31st Mar 20235:14 pmRNSRemoval of Reg S restrictions from shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.